131 related articles for article (PubMed ID: 34088935)
1. The first competing risk survival nomogram in patients with papillary renal cell carcinoma.
Su X; Hou NN; Yang LJ; Li PX; Yang XJ; Hou GD; Gao XL; Ma SJ; Guo F; Zhang R; Zhang WH; Qin WJ; Wang FL
Sci Rep; 2021 Jun; 11(1):11835. PubMed ID: 34088935
[TBL] [Abstract][Full Text] [Related]
2. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
3. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
Front Public Health; 2022; 10():989566. PubMed ID: 36276376
[TBL] [Abstract][Full Text] [Related]
4. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
5. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
6. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
7. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
[TBL] [Abstract][Full Text] [Related]
9. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
Klatte T; Remzi M; Zigeuner RE; Mannweiler S; Said JW; Kabbinavar FF; Haitel A; Waldert M; de Martino M; Marberger M; Belldegrun AS; Pantuck AJ
J Urol; 2010 Jul; 184(1):53-8. PubMed ID: 20478577
[TBL] [Abstract][Full Text] [Related]
10. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.
Zhanghuang C; Wang J; Yao Z; Li L; Xie Y; Tang H; Zhang K; Wu C; Yang Z; Yan B
Front Public Health; 2022; 10():874427. PubMed ID: 35444972
[TBL] [Abstract][Full Text] [Related]
12. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
13. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
Int J Urol; 2015 Mar; 22(3):264-70. PubMed ID: 25428139
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
Huang J; Huang D; Yan J; Chen T; Gao Y; Xu D; Na R
Cancer Med; 2020 Dec; 9(24):9409-9418. PubMed ID: 33141518
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma.
Trudeau V; Larcher A; Sun M; Boehm K; Dell'Oglio P; Sosa J; Tian Z; Fossati N; Briganti A; Shariat SF; Karakiewicz PI
World J Urol; 2016 Oct; 34(10):1429-36. PubMed ID: 26902877
[TBL] [Abstract][Full Text] [Related]
17. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study.
Hou G; Li X; Zheng Y; Liu P; Yan F; Ju D; Zhang G; Zheng W; Gao M; Hou N; Yuan J; Wang F; Yuan J
Int J Clin Oncol; 2020 Jul; 25(7):1356-1363. PubMed ID: 32361824
[TBL] [Abstract][Full Text] [Related]
20. A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases.
Sheng X; Lu X; Wu J; Chen L; Cao H
Biomed Res Int; 2021; 2021():6627562. PubMed ID: 33791367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
